For cerebral sinovenous thrombosis without evidence of haemorrhage on parenchymal
neuroimaging, there was an agreement among all guidelines to treat older children (non …

Stroke is as common as brain tumor in children and results in Iong-term morbidity in at least
two thirds of survivors. There has been a recent explosion of research in the field of …

Early treatment of stroke in children and infants is essential, but success is not supported by
data. Recent studies have demonstrated a mortality rate of up to 3%-11% and persistent …

Background: Ischaemic stroke (arterial ischaemic stroke and cerebral sinovenous
thrombosis) is increasingly recognised in childhood and has a significant attendant …

These begin from the point of referral or the activation and response of emergency medical
services and go through to long-term community care, covering the management pathway …

The past decade has seen a dramatic increase in pediatric stroke research. However few
studies have addressed anti-thrombotic safety or effectiveness. Three paediatric stroke …

Cerebral sinovenous thrombosis (CSVT) is a rare but serious cerebrovascular disorder
affecting children from the newborn period through childhood and adolescence. The …

Children often are treated with antiplatelet agents and anticoagulants, and sometimes they
are given thrombolytic agents. Without age-specific clinical trials of these agents, we must try …

Continued developments in understanding and practice in childhood stroke are
encouraging. However, the absence of clinical trials and evidence-based guidelines is …

Because no gold-standard outcome measure or measures exist to allow comparison of
pediatric stroke study outcomes in clinical trials, we designed a systematic review of the …